WCN26-2597 SAFE MYCOPHENOLATE INDUCTION AFTER COMPLETING RECOMMENDED VACCINATIONS IN LUPUS NEPHRITIS WITH SPLENIC HYPOPLASIA: A CASE REPORT

Read full text Summarise with VIRAT
Authors: Kosei Okamoto, Kazuhiro Yoshikawa, Yuki Matsuura, Seiya Noda, 武寿 佐藤, Koichi Asahi
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

The spleen plays a role in immune function and helps prevent infectious diseases. Patients with post-splenectomy status and impaired splenic function, including splenic hypoplasia are susceptible to infections caused by encapsulated bacteria—Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae type b (Hib). We hereby report a didactic case of lupus nephritis (LN) in a patient suffering from splenic hypoplasia, managed with immunosuppressive therapy after complete vaccinations.

Fields of Study & Subjects

Systemic Lupus Erythematosus Research Renal Transplantation Outcomes and Treatments Renal Diseases and Glomerulopathies

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
106189–106189
Publication date
25 March 2026
Language
EN